Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 10.830% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: CCCCc1n[nH]c2c1/C(=N/OCC)CC(C)(C)C2
b: CCS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCOCC1
c: O=C(CN1C(=O)N/C(=C\c2ccccc2OCc2ccc(C(=O)O)cc2)C1=O)Nc1ccccc1F
Answer: b. CCS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCOCC1
CCS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCOCC1
2-(2-ethylsulfonylbenzimidazol-1-yl)-1-morpholin-4-ylethanone